IMNR Insider Trading Activity and SEC Form 4 Filings
IMNR insider trading summary
No open-market insider purchases or sales of Immune Response Corp (IMNR) have been reported on SEC Form 4 in the past 12 months.
Latest IMNR insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Aug 21, 2006 | David P Hochman | Director | Buy | $9K (500,000 @ $0.02) |
| Jul 28, 2006 | David P Hochman | Director | Buy | $60K (2,600,000 @ $0.02) |
| Jul 27, 2006 | David P Hochman | Director | Buy | $7K (300,000 @ $0.02) |
| Jun 19, 2006 | David P Hochman | Director | Buy | $4K (200,000 @ $0.02) |
| Jun 14, 2006 | David P Hochman | Director | Buy | $10K (500,000 @ $0.02) |
| Dec 30, 2005 | Kevin Kimberlin | Director | Sell | $0 (3,496,000 @ $0.00) |
| Sep 22, 2005 | Kevin Kimberlin | Director | Buy | $0 (9,643,060 @ $0.00) |
| Sep 6, 2005 | Michael K Green | VP, Finance and CFO | Buy | $15K (30,000 @ $0.50) |
| Sep 2, 2005 | John N Bonfiglio | CEO | Buy | $5K (10,000 @ $0.46) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.